BMS-200,475, a new anti-hepatitis B compound; Metabolic studies and comparison with 3TC, penciclovir, and lobucavir: G. Yamanaka*, T.M. Wilson, S.F. Innaimo, and R.J. Colonno. Bristol-Myers Squibb Pharm. Res. Inst., Wallingford, CT

• Book ID: 114145034
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 95 KB
• Volume: 34
• Category: Article
• ISSN: 0166-3542
• DOI: 10.1016/s0166-3542(97)83219-6